Pneumococcal Vaccine Market Report

Europe Pneumococcal Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Apr 01, 2020
  • PAGES：194
  • REPORT CODE：GMM529353
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pneumococcal Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pneumococcal Vaccine Market Segmentations:

    By Player:

    • CDIBP

    • MSD

    • Sanofipasteur

    • Pfizer

    • GSK

    By Type:

    • PPSV 23

    • PCV 7/13

    • PCV 10

    By End-User:

    • Infants

    • Children (2-10)

    • Person (10-64)

    • The old (=65)

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pneumococcal Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pneumococcal Vaccine Market Size and Growth Rate of PPSV 23 from 2014 to 2026

    • 1.3.2 Europe Pneumococcal Vaccine Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

    • 1.3.3 Europe Pneumococcal Vaccine Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pneumococcal Vaccine Market Size and Growth Rate of Infants from 2014 to 2026

    • 1.4.2 Europe Pneumococcal Vaccine Market Size and Growth Rate of Children (2-10) from 2014 to 2026

    • 1.4.3 Europe Pneumococcal Vaccine Market Size and Growth Rate of Person (10-64) from 2014 to 2026

    • 1.4.4 Europe Pneumococcal Vaccine Market Size and Growth Rate of The old (=65) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pneumococcal Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pneumococcal Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of PPSV 23

      • 3.4.2 Market Size and Growth Rate of PCV 7/13

      • 3.4.3 Market Size and Growth Rate of PCV 10

    4 Segmentation of Pneumococcal Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pneumococcal Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pneumococcal Vaccine for Infants

      • 4.4.2 Market Size and Growth Rate of Pneumococcal Vaccine for Children (2-10)

      • 4.4.3 Market Size and Growth Rate of Pneumococcal Vaccine for Person (10-64)

      • 4.4.4 Market Size and Growth Rate of Pneumococcal Vaccine for The old (=65)

    5 Market Analysis by Major Regions

    • 5.1 Europe Pneumococcal Vaccine Production Analysis by Top Regions

    • 5.2 Europe Pneumococcal Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Pneumococcal Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pneumococcal Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Pneumococcal Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pneumococcal Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pneumococcal Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pneumococcal Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pneumococcal Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pneumococcal Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pneumococcal Vaccine Landscape Analysis

    • 7.1 Germany Pneumococcal Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Pneumococcal Vaccine Landscape Analysis by Major End-Users

    8. UK Pneumococcal Vaccine Landscape Analysis

    • 8.1 UK Pneumococcal Vaccine Landscape Analysis by Major Types

    • 8.2 UK Pneumococcal Vaccine Landscape Analysis by Major End-Users

    9. France Pneumococcal Vaccine Landscape Analysis

    • 9.1 France Pneumococcal Vaccine Landscape Analysis by Major Types

    • 9.2 France Pneumococcal Vaccine Landscape Analysis by Major End-Users

    10. Italy Pneumococcal Vaccine Landscape Analysis

    • 10.1 Italy Pneumococcal Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Pneumococcal Vaccine Landscape Analysis by Major End-Users

    11. Spain Pneumococcal Vaccine Landscape Analysis

    • 11.1 Spain Pneumococcal Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Pneumococcal Vaccine Landscape Analysis by Major End-Users

    12. Poland Pneumococcal Vaccine Landscape Analysis

    • 12.1 Poland Pneumococcal Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Pneumococcal Vaccine Landscape Analysis by Major End-Users

    13. Russia Pneumococcal Vaccine Landscape Analysis

    • 13.1 Russia Pneumococcal Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Pneumococcal Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Pneumococcal Vaccine Landscape Analysis

    • 14.1 Switzerland Pneumococcal Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Pneumococcal Vaccine Landscape Analysis by Major End-Users

    15. Turkey Pneumococcal Vaccine Landscape Analysis

    • 15.1 Turkey Pneumococcal Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Pneumococcal Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pneumococcal Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Pneumococcal Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Pneumococcal Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Pneumococcal Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Pneumococcal Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pneumococcal Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Pneumococcal Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pneumococcal Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pneumococcal Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Pneumococcal Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Pneumococcal Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 CDIBP

      • 19.1.1 CDIBP Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 MSD

      • 19.2.1 MSD Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Sanofipasteur

      • 19.3.1 Sanofipasteur Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Pfizer

      • 19.4.1 Pfizer Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 GSK

      • 19.5.1 GSK Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    The List of Tables and Figures (Totals 86 Figures and 114 Tables)

    • Figure Product Picture

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of PPSV 23 from 2014 to 2026

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of Infants from 2014 to 2026

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of Children (2-10) from 2014 to 2026

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of Person (10-64) from 2014 to 2026

    • Figure Europe Pneumococcal Vaccine Market Size and Growth Rate of The old (=65) from 2014 to 2026

    • Figure Germany Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pneumococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pneumococcal Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pneumococcal Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pneumococcal Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of PPSV 23

    • Figure Market Size and Growth Rate of PCV 7/13

    • Figure Market Size and Growth Rate of PCV 10

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pneumococcal Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infants

    • Figure Market Size and Growth Rate of Children (2-10)

    • Figure Market Size and Growth Rate of Person (10-64)

    • Figure Market Size and Growth Rate of The old (=65)

    • Table Europe Pneumococcal Vaccine Production by Major Regions

    • Table Europe Pneumococcal Vaccine Production Share by Major Regions

    • Figure Europe Pneumococcal Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Pneumococcal Vaccine Consumption by Major Regions

    • Table Europe Pneumococcal Vaccine Consumption Share by Major Regions

    • Table Germany Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table France Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pneumococcal Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pneumococcal Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pneumococcal Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pneumococcal Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table UK Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table France Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pneumococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of CDIBP

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CDIBP

    • Figure Sales and Growth Rate Analysis of CDIBP

    • Figure Revenue and Market Share Analysis of CDIBP

    • Table Product and Service Introduction of CDIBP

    • Table Company Profile and Development Status of MSD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MSD

    • Figure Sales and Growth Rate Analysis of MSD

    • Figure Revenue and Market Share Analysis of MSD

    • Table Product and Service Introduction of MSD

    • Table Company Profile and Development Status of Sanofipasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofipasteur

    • Figure Sales and Growth Rate Analysis of Sanofipasteur

    • Figure Revenue and Market Share Analysis of Sanofipasteur

    • Table Product and Service Introduction of Sanofipasteur

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US